Pages that link to "Q24642892"
Jump to navigation
Jump to search
The following pages link to Narcolepsy (Q24642892):
Displaying 39 items.
- Antidepressant drugs for narcolepsy (Q24242527) (← links)
- Antidepressant drugs for narcolepsy (Q24246597) (← links)
- Relative Efficacy of Drugs for the Treatment of Sleepiness in Narcolepsy (Q24646036) (← links)
- Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate (Q24658233) (← links)
- A clinician's guide to recurrent isolated sleep paralysis (Q26739866) (← links)
- What is causing excessive daytime sleepiness? Evaluation to distinguish sleep deprivation from sleep disorders (Q28139377) (← links)
- Treatment of narcolepsy with methamphetamine (Q28260934) (← links)
- Narcolepsy: new understanding of irresistible sleep (Q32049276) (← links)
- Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations (Q33770253) (← links)
- Sleep disorders (Q34084996) (← links)
- Effect of levothyroxine on prolonged nocturnal sleep time and excessive daytime somnolence in patients with idiopathic hypersomnia (Q34629131) (← links)
- Pharmacological aspects of human and canine narcolepsy (Q34740875) (← links)
- Benefits and risks of pharmacotherapy for narcolepsy. (Q34836843) (← links)
- Narcolepsy: a review (Q35212990) (← links)
- The more unusual sleep disturbances of childhood (Q35775082) (← links)
- Clinical and neurobiological aspects of narcolepsy (Q35995182) (← links)
- Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand (Q36082764) (← links)
- Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia (Q36411331) (← links)
- A normative study of the maintenance of wakefulness test (MWT) (Q36713776) (← links)
- Methods of testing for sleepiness [corrected] (Q36775767) (← links)
- Treatment Options for Parasomnias (Q37785182) (← links)
- Treatment Options for Narcolepsy (Q38828355) (← links)
- Management of Narcolepsy. (Q38828918) (← links)
- Can transcranial magnetic stimulation be used to evaluate patients with narcolepsy? (Q39512236) (← links)
- Comparative tolerability profiles of the newer versus older antidepressants (Q40729277) (← links)
- Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours. (Q41422767) (← links)
- Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers (Q42686040) (← links)
- Effects of Thyrotropin-Releasing Hormone and Its Analogs on Daytime Sleepiness and Cataplexy in Canine Narcolepsy (Q44605517) (← links)
- Treatment of disorders of hypersomnolence. (Q46026424) (← links)
- Current concepts in the etiology, diagnosis and treatment of narcolepsy (Q48706440) (← links)
- Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndrome (Q48712637) (← links)
- Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy (Q48714693) (← links)
- Sleep disorders presenting as psychiatric disorders (Q48786723) (← links)
- Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs (Q48787988) (← links)
- Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy (Q56057681) (← links)
- What we learned from narcolepsy of others (Q73214033) (← links)
- Sleep latency measures of caffeine effects during sleep deprivation (Q73434630) (← links)
- Psychological and neurophysiological dysfunctioning during wakefulness in narcolepsy (Q87438089) (← links)
- Therapeutic Symptomatic Strategies in the Parasomnias (Q88990610) (← links)